SCHEMBL24113103

SCHEMBL24113103

CC(C)(C)OC(=O)NC(CC1CCNC1=O)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24013950 1.00 CTSL (0.42) CTSL
SCHEMBL24020461 1.00 CTSL (0.42) CTSL
SCHEMBL25835207 1.00 CTSL (0.42) CTSL
Ammonia Solution, Strong SCHEMBL26119246 0.99 CTSL (0.41) CTSL
SCHEMBL25134723 0.93 CTSS (0.40) —
SCHEMBL24754818 0.93 CTSS (0.40) —
SCHEMBL24113318 0.93 CTSS (0.40) —
SCHEMBL24425123 0.92 — —
SCHEMBL28732881 0.92 — —
SCHEMBL24690562 0.91 CTSL (0.51) CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055702-A1 MAIN PROTEASE (M PRO) INHIBITORS AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2023-04-06 — — WO disclosed
WO-2022266363-A1 PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2022-12-22 — — WO disclosed
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 — — WO disclosed
Send feedback